SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit Therapeutics is trending as investors monitor ongoing clinical trials and the upcoming late-year FDA decision for ivonescimab, while debating the significance of recent data readouts. The community is actively tracking the stock's potential for institutional interest and acquisition rumors, often drawing comparisons to other high-profile oncology competitors.

Gladstone Investment Corp., a traded business development company, which engages in the provision of lower middle market companies located in the United States. The fund focuses on companies with an EBITDA of USD 4 - 15 million. It targets companies operating in the fields of manufacturing, consumer products and business and consumer services. It provides financing for debt, buyout and growth stage capital requirements with an investment size up to USD 75 million. The company was founded in 2005 and is headquartered in McLean, VA.

Gladstone Investment Corporation

Gladstone Investment (GAIN) is trending as investors debate the impact of the viral NeeDoh toy craze on the company's portfolio performance and potential for future supplemental dividends. While some shareholders are taking profits amid recent share price volatility, others are emphasizing the company's consistent monthly payouts and strong, debt-free portfolio quality as a margin of safety.

NXP Semiconductors NV is a holding company which engages in the provision of semiconductor solutions. It operates through the following geographical segments: China, Netherlands, United States, Singapore, Germany, Japan, South Korea, Malaysia, and Other Countries. The company was founded on August 2, 2006, and is headquartered in Eindhoven, the Netherlands.

NXP Semiconductors NV

NXP Semiconductors (NXPI) is trending as institutional investors rotate into automotive and industrial silicon plays following broad-market volatility and robust earnings reactions. The community is actively discussing the company's breakout potential as it positions itself as a critical player in AI-enabled automotive infrastructure and edge computing.

Stellar is an open-source, decentralized network co-founded in 2014 by Jed McCaleb and Joyce Kim to facilitate the fast and low-cost transfer of value across different currencies and assets globally. Managed by the non-profit Stellar Development Foundation, the project serves as a global infrastructure that connects banks, payment systems, and individuals to expand financial access to underserved populations. Its main value proposition lies in providing a bridge between traditional money and digital networks through the use of Anchors, which are trusted entities that hold deposits and issue credits on the ledger.  The network operates using the Stellar Consensus Protocol and a Federated Byzantine Agreement, where nodes choose trusted sets of other nodes to agree on the state of the ledger. This system ensures high throughput and fast finality, where transactions are considered permanent and irreversible within seconds. Key features include a built-in distributed exchange for trading assets without intermediaries and the Soroban platform for developing smart contracts. Users can also utilize the network for tokenizing real-world assets or accessing decentralized finance services like peer-to-peer lending.  Stellar's native token, XLM, is essential for maintaining network integrity by acting as an intermediary to find efficient exchange paths and preventing spam through small transaction fees and minimum account balance requirements. Unlike many other digital assets, the network has no inflation because the community voted to disable the automatic creation of new tokens. While the project received early funding from the payments company Stripe, it is now sustained by a global community of validators and developers rather than traditional venture capital.

Stellar Lumens

Stellar Lumens is trending significantly as investors react to the DTCC's selection of the network to support its massive, trillion-dollar asset tokenization infrastructure. The community is actively debating the project's long-term utility against traditional finance requirements, with many speculating on future price potential as the market reacts to the news of institutional integration.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Johnson & Johnson

Johnson & Johnson is currently in the spotlight as investors weigh strong fourth-quarter financial results and bullish 2026 growth guidance against ongoing concerns surrounding the impact of patent expirations and active talc litigation. Market conversation is particularly focused on the company's ability to drive its Innovative Medicine and MedTech segments to sustain long-term growth while managing significant legal liabilities.

Open Text Corp. engages in the design, development, marketing and sales of enterprise information management software and solutions. It includes customer experience management (CEM), digital process automation, business network, and enterprise content management, discovery, security, and artificial intelligence (AI) and analytics solutions. It also offers consulting, managed, and learning services. The company was founded on June 26, 1991 and is headquartered in Waterloo, Canada.

Open Text Corp

Open Text is garnering attention as investors and the community weigh its consistent cloud-driven growth and dividend yield against concerns about its recent stock price performance and long-term relevance. While some are optimistic about the firm's strategic focus on AI and cloud-based information management, others remain skeptical, focusing on the potential for market saturation and the ongoing challenge of sustaining growth in a competitive software environment.

Hewlett Packard Enterprise Co. is a global edge-to-cloud company, which engages in the provision of information technology, technology and enterprise products, solutions, and services. It operates through the following segments: Server, Hybrid Cloud, Intelligent Edge, Financial Services, and Corporate Investments and Other. The Server segment consists of general-purpose servers for multi-workload computing and workload-optimized servers to deliver the performance and value for demanding applications, and integrated systems comprised of software and hardware designed to address high-performance computing and supercomputing, artificial intelligence, data analytics, and transaction processing workloads for government and commercial customers globally. The Hybrid Cloud segment is involved in a variety of cloud-native and hybrid solutions across storage, private cloud, and the infrastructure software-as-a-service space. The Intelligent Edge segment offers wired and wireless local area networks, campus, branch, and data center switching, software-defined wide-area-networks, private and public cellular network software, network security, and associated services that enable secure connectivity for businesses of any size. The Financial Services segment provides investment solutions, such as leasing, financing, IT consumption, utility programs, and asset management services for customers that facilitate technology deployment models and the acquisition of complete IT solutions, including hardware, software, and services from Hewlett Packard Enterprise and others. The Corporate Investments and Other segment includes the Advisory and Professional Services business, which primarily offers consultative-led services, HPE and partner technology expertise and advice, implementation services, as well as complex solution engagement capabilities, the Communications and Media Solutions business, which primarily offers software and related services to the telecommunications industry, and Hewlett Packard Labs, which is responsible for research and development. The company was founded by William R. Hewlett and David Packard on July 2, 1939 and is headquartered in Spring, TX.

Hewlett Packard Enterprise Co

Hewlett Packard Enterprise is trending as the community debates its $931 million defense contract, balancing optimism for structural growth against concerns regarding margin pressures and the integration of Juniper Networks. Traders are closely monitoring the stock ahead of upcoming quarterly results, with active discussions focusing on its AI infrastructure backlog and its competitive standing against server peers like Dell and Super Micro.

Bubble Protocol (BPL) is the utility token powering the BubbleSwap ecosystem on Shido Network.  BPL is designed to reduce trading fees, reward long-term holders through staking, and provide access to ecosystem opportunities such as BubblePad airdrops.  With a fixed supply of 20M tokens and a buyback &amp; burn mechanism tied to protocol activity, BPL is built around real usage and growth, not speculation.

Bubble Protocol

Bubble Protocol is gaining momentum as investors highlight its expanding suite of DeFi tools on the Shido Network, including a new gasless smart account feature and automated token-burning mechanics. The community is actively discussing the project's ecosystem growth and its recent listings on major data platforms as they look for long-term utility within the Shido infrastructure.

Shido DEX is the flagship decentralized exchange and automated market maker on the Shido Network. The platform offers a wide range of features for traders, including cross-chain transfers, limit orders and one-click swaps.  Easily trade any token on the Shido Network using Shido DEX. Bridge assets from the most prominent ecosystems in the industry.  Discover the Shido ecosystem and unlock the power of decentralized trading with Shido DEX.

Shido DEX

The Shido ecosystem is capturing significant attention as the community celebrates a flurry of network-wide upgrades, including the launch of the Shido DEX V4 interface, the introduction of gasless BubbleAccount smart wallets, and ongoing deflationary token burning mechanisms. Traders and developers are actively discussing these technological advancements as the network expands its cross-chain capabilities and pushes toward future performance improvements like the Nova architecture.

Shido

Shido is generating significant buzz as its ecosystem expands with major infrastructure milestones, including the upcoming Nova EVM mainnet launch and the integration of advanced DeFi tools like the Shido Gateway and DEX V5. Community discussions are centered on the project's institutional-grade scalability and the potential for a new deflationary era driven by consistent on-chain burn mechanisms.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SLS Stock Rises Overnight: Traders Rally Behind Jim Cramer's 'Two Thumbs Up' Call Ahead Of Key AML Readout 

Equity

CEO Angelos Stergiou said the trial's extended duration suggests patients are living longer than originally projected and said the company remains "very bullish."

SLS Stock Extends Rally Overnight: CEO Says ‘Bullish’ Leukemia Data Could Drive NCCN Recognition For GPS

Sellas believes GPS-treated AML patients could live longer than those receiving standard treatment, with a projected survival of about 12.6 months versus 8 months.

SLS Stock Surges Toward Fifth Weekly Rise: CEO Touts GPS As Lifeline For Elderly Patients As Cancer Summit Looms

Sellas will participate Wednesday in TD Cowen’s Oncology Innovation Summit, marking the final major conference appearance ahead of the Regal data release.

SLS Stock Heads For Its Best Month This Year Ahead Of Key AML Trial Readout 

The company plans to move quickly toward a pre-BLA meeting with the FDA and a potential filing if the REGAL trial reports positive results.

SLS Stock Tanks Hard: Retail Traders Blame Warrant Holders, 'Flippers' Cashing Out Before AML Catalyst

Retail speculation intensified as short interest in SLS climbed to a record high of 30.7% ahead of the final Regal catalyst.

SLS Stock Hits Over 4-Year High: CEO Eyes FDA Talks, ‘Whole Gamut’ Of Cancer Uses For GPS 

Beyond leukemia, Sellas said GPS could potentially expand into up to 20 different tumor types. 

Why Did ARM, SLS, EBAY Stocks Surge To 52-Week Highs?

Arm Holdings surged more than 15%, while Sellas Life Sciences rallied by over 18% and eBay climbed up 4% at close. 

Biotech and Biologics Break Out: These Tiny Stocks Are Suddenly Dominating the Market Conversation

Emerging biotech and biologics names exploded onto traders’ radar Wednesday as a wave of clinical milestones, regulatory momentum, strategic acquisitions, and high-volume technical breakouts fueled aggressive speculation across the sector. $HCWB, $TGNT, $KBLB, $SLS, $RKDA, $ROIV, $SLXN

SELLAS Life Sciences Stock Is Surging Wednesday: What's Driving The Move?

Sellas Life Sciences shares are rising Wednesday after its latest update on acute myeloid leukemia pipeline and Phase 3 readout timeline.read more...

Nasdaq, S&P 500 Futures Higher As Nvidia Earnings Take Center Stage: Why TSLA, SLS, IBRX, CAVA, POET, BA Are Keeping Traders Engaged Today

Data from Stocktwits shows that retail sentiment continues to lean optimistic on SPY and QQQ. 


SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Extremely Bullish Sentiment

Investors are awaiting final trial data as the 80th event trigger approaches, anticipating massive valuation shifts upon unblinding.

Rumors of a multi-billion dollar acquisition dominate the discourse, with traders citing patent cliffs as motivation for big pharma to secure assets.

Bulls are tracking high short interest and institutional activity, preparing for an aggressive volatility spike when data results are released.

Deep-value discussions emphasize the broader multi-indication potential of the pipeline beyond AML as the primary driver for a long-term premium.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '27	--	-$0.13	--	N/A
Q1 '27	--	-$0.05	--	N/A
Q2 '26	-$0.05	--	--	N/A
Q1 '26	-$0.06	-$0.05	16.67%	BEAT
Q4 '25	-$0.06	-$0.05	21.05%	BEAT

SLS
SELLAS Life Sciences Group Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q2 '27

Historical Earnings

Compact View

Latest SLS News

SLSSELLAS Life Sciences Group Inc